Idaho Technology Awarded 2007 North American Biological Detection Company of the Year Award

Share Article

Idaho Technology Inc. was selected as the recipient of the 2007 North American Biological Detection Company of the Year Award. This award is given for becoming a leading biological and life science company in a short span, despite the challenges posed by large and established companies.

Idaho Technology Inc. (ITI) was selected as the recipient of the 2007 North American Biological Detection Company of the Year Award. This award is given for becoming a leading biological and life science company in a short span, despite the challenges posed by large and established companies.

Although the company was a success before 9/11, it was the aftermath of that day and the ensuing climate of insecurity that put ITI on the fast track. Favorable climate, along with the company's ability to expand into new markets gave ITI a significant thrust and set it apart from its competitors. "Our company is centered on the science of rapid molecular biology. At ITI, we strive to be on the cutting edge of science and have a unique way of being able to apply it to unusual testing environments and applications. This gives our various market sector customers great flexibility and allows them to be much more creative," says Todd Ritter, Chief Corporate Development Officer at Idaho Technology.

ITI offers a complete solution for pathogen identification that have been specifically designed for military field hospitals, first responders, and other harsh environments. Their systems integrate technology shared with the LightCycler® instrument into a portable, rugged package.

ITI's flagship pathogen identification system is the Ruggedized Advanced Pathogen Identification Device (R.A.P.I.D.®). In 2003, ITI was awarded the Joint Biological Agent Identification and Diagnostic System (JBAIDS) contract giving ITI the opportunity to provide an updated version of the R.A.P.I.D. system to the four branches of the U.S. Military: U.S. Army, U.S. Navy, U.S. Air Force, and U.S. Marine Corps.

ITI's RAZOR® instrument is compact, lightweight, and easy to use. It is a field polymerase chain reaction (PCR) unit that provides fast, ultrareliable, DNA-based results. Created for first responders and front-line military troops, the RAZOR is easily operated while working in protective equipment under extreme conditions. Battery powered with a simple user interface, the system has post-mission PC software for data archiving and reporting.

In addition to ITI's instrumentation, they have an expanding list of test kits allowing users to test everything from Anthrax to E. coli to Avian Influenza. Each kit is optimized and validated for their instruments. ITI has sold millions of tests worldwide and continues to develop tests in response to public health concerns and military needs.

The award is presented by Frost & Sullivan, a consulting firm that recognizes companies in a variety of regional and global markets. Companies must demonstrate outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research to identify best practices in the industry.

About Idaho Technology, Inc.
Idaho Technology Inc., based in Salt Lake City, UT, is the originator of rapid DNA analysis with applications including DNA amplification, real-time PCR, and mutation discovery. Idaho Technology's systems include biothreat detection systems (R.A.P.I.D.® and RAZOR® systems), biomedical research systems for gene quantification and mutation scanning (LightCycler® sold by Roche Diagnostics and LightScanner® systems), and food protection systems (R.A.PI.D. ® LT). Founded in 1990, Idaho Technology Inc. is a privately held company focused on worldwide applications in the defense, research, industrial and food testing markets. For more information, please visit http://www.idahotech.com.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

MARK KESSLER
Visit website